A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3
Background: Non-alcohol fatty liver disease (NAFLD) is the most prevalent hepatopathy in China, with few effective cures currently. This work aimed to confirm the effect of DHM in vivo/vitro and explore the potential mechanism based on a network pharmacology-based approach. Methods: The rats were fe...
Main Authors: | Lu Liu, Sen Sun, Xiaohua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Molecular and Cellular Probes |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S089085082300035X |
Similar Items
-
A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice
by: Joshua Silva, et al.
Published: (2021-03-01) -
Study on Dihydromyricetin Improving Aflatoxin Induced Liver Injury Based on Network Pharmacology and Molecular Docking
by: Xiaoying Zhu, et al.
Published: (2023-09-01) -
Study the Effect of Eugenol on CASP8 and CASP9 Gene\'s Expression in Colon Cancer Cell Lines HT-29
by: Milad Banitalebi Dehkordi, et al.
Published: (2019-12-01) -
Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
by: Jingyao Zhang, et al.
Published: (2018-10-01) -
PPARG expression patterns and correlations in obesity
by: Noura M. Darwish, et al.
Published: (2022-08-01)